A citation-based method for searching scientific literature

Jill Bouchard, Jennifer Truong, Kristofer Bouchard, Diana Dunkelberger, Sandrine Desrayaud, Saliha Moussaoui, Sarah J Tabrizi, Nephi Stella, Paul J Muchowski. J Neurosci 2012
Times Cited: 85







List of co-cited articles
1239 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.
Maria Björkqvist, Edward J Wild, Jenny Thiele, Aurelio Silvestroni, Ralph Andre, Nayana Lahiri, Elsa Raibon, Richard V Lee, Caroline L Benn, Denis Soulet,[...]. J Exp Med 2008
393
47

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.
Javier Palazuelos, Tania Aguado, M Ruth Pazos, Boris Julien, Carolina Carrasco, Eva Resel, Onintza Sagredo, Cristina Benito, Julián Romero, Iñigo Azcoitia,[...]. Brain 2009
250
40


Abnormal peripheral chemokine profile in Huntington's disease.
Edward Wild, Anna Magnusson, Nayana Lahiri, Ulrika Krus, Michael Orth, Sarah J Tabrizi, Maria Björkqvist. PLoS Curr 2011
68
38

Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease.
Onintza Sagredo, Sara González, Ilia Aroyo, María Ruth Pazos, Cristina Benito, Isabel Lastres-Becker, Juan P Romero, Rosa M Tolón, Raphael Mechoulam, Emmanuel Brouillet,[...]. Glia 2009
120
30

Microglial activation in presymptomatic Huntington's disease gene carriers.
Yen F Tai, Nicola Pavese, Alexander Gerhard, Sarah J Tabrizi, Roger A Barker, David J Brooks, Paola Piccini. Brain 2007
280
28

Bone marrow transplantation confers modest benefits in mouse models of Huntington's disease.
Wanda Kwan, Anna Magnusson, Austin Chou, Anthony Adame, Monica J Carson, Shinichi Kohsaka, Eliezer Masliah, Thomas Möller, Richard Ransohoff, Sarah J Tabrizi,[...]. J Neurosci 2012
54
40

HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation.
Ulrike Träger, Ralph Andre, Nayana Lahiri, Anna Magnusson-Lind, Andreas Weiss, Stephan Grueninger, Chris McKinnon, Eva Sirinathsinghji, Shira Kahlon, Edith L Pfister,[...]. Brain 2014
103
25

Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates.
Annette Dalrymple, Edward J Wild, Richard Joubert, Kirupa Sathasivam, Maria Björkqvist, Asa Petersén, Graham S Jackson, Jeremy D Isaacs, Mark Kristiansen, Gillian P Bates,[...]. J Proteome Res 2007
154
24

Mutant huntingtin impairs immune cell migration in Huntington disease.
Wanda Kwan, Ulrike Träger, Dimitrios Davalos, Austin Chou, Jill Bouchard, Ralph Andre, Aaron Miller, Andreas Weiss, Flaviano Giorgini, Christine Cheah,[...]. J Clin Invest 2012
89
23

Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration.
Daniel Zwilling, Shao-Yi Huang, Korrapati V Sathyasaikumar, Francesca M Notarangelo, Paolo Guidetti, Hui-Qiu Wu, Jason Lee, Jennifer Truong, Yaisa Andrews-Zwilling, Eric W Hsieh,[...]. Cell 2011
332
22

Early and progressive accumulation of reactive microglia in the Huntington disease brain.
E Sapp, K B Kegel, N Aronin, T Hashikawa, Y Uchiyama, K Tohyama, P G Bhide, J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 2001
345
21

Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity.
Ali Khoshnan, Jan Ko, Erin E Watkin, Lisa A Paige, Peter H Reinhart, Paul H Patterson. J Neurosci 2004
151
18

Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression.
Andreas Weiss, Ulrike Träger, Edward J Wild, Stephan Grueninger, Ruth Farmer, Christian Landles, Rachael I Scahill, Nayana Lahiri, Salman Haider, Douglas Macdonald,[...]. J Clin Invest 2012
89
18

Microglial activation correlates with severity in Huntington disease: a clinical and PET study.
N Pavese, A Gerhard, Y F Tai, A K Ho, F Turkheimer, R A Barker, D J Brooks, P Piccini. Neurology 2006
281
17

A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.
Han-Yun Hsiao, Yu-Chen Chen, Hui-Mei Chen, Pang-Hsien Tu, Yijuang Chern. Hum Mol Genet 2013
131
17

Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.
Andrea Crotti, Christopher Benner, Bilal E Kerman, David Gosselin, Clotilde Lagier-Tourenne, Chiara Zuccato, Elena Cattaneo, Fred H Gage, Don W Cleveland, Christopher K Glass. Nat Neurosci 2014
188
17

Distinct neuroinflammatory profile in post-mortem human Huntington's disease.
Aurelio Silvestroni, Richard L M Faull, Andrew D Strand, Thomas Möller. Neuroreport 2009
109
16

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
16

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
Cristina Blázquez, Anna Chiarlone, Onintza Sagredo, Tania Aguado, M Ruth Pazos, Eva Resel, Javier Palazuelos, Boris Julien, María Salazar, Christine Börner,[...]. Brain 2011
125
16

A restricted population of CB1 cannabinoid receptors with neuroprotective activity.
Anna Chiarlone, Luigi Bellocchio, Cristina Blázquez, Eva Resel, Edgar Soria-Gómez, Astrid Cannich, José J Ferrero, Onintza Sagredo, Cristina Benito, Julián Romero,[...]. Proc Natl Acad Sci U S A 2014
105
16

CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AβPP/PS1 mice.
Ester Aso, Salvador Juvés, Rafael Maldonado, Isidro Ferrer. J Alzheimers Dis 2013
127
16

CB2: a cannabinoid receptor with an identity crisis.
Brady K Atwood, Ken Mackie. Br J Pharmacol 2010
410
15

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
Cristina Benito, Estefanía Núñez, Rosa M Tolón, Erica J Carrier, Alberto Rábano, Cecilia J Hillard, Julián Romero. J Neurosci 2003
395
15

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Belén G Ramírez, Cristina Blázquez, Teresa Gómez del Pulgar, Manuel Guzmán, María L de Ceballos. J Neurosci 2005
523
15

Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models.
Ulrike Träger, Ralph Andre, Anna Magnusson-Lind, James R C Miller, Colúm Connolly, Andreas Weiss, Stephan Grueninger, Edina Silajdžić, Donna L Smith, Blair R Leavitt,[...]. Neurobiol Dis 2015
36
36

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
958
14

Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease.
Sonia Franciosi, Jae K Ryu, Yaein Shim, Austin Hill, Colum Connolly, Michael R Hayden, James G McLarnon, Blair R Leavitt. Neurobiol Dis 2012
73
16

The role of the immune system in Huntington's disease.
Gisa Ellrichmann, Christiane Reick, Carsten Saft, Ralf A Linker. Clin Dev Immunol 2013
88
14


Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
Yolanda Gómez-Gálvez, Cristina Palomo-Garo, Javier Fernández-Ruiz, Concepción García. Prog Neuropsychopharmacol Biol Psychiatry 2016
109
14

Beyond the brain: widespread pathology in Huntington's disease.
Jorien M M van der Burg, Maria Björkqvist, Patrik Brundin. Lancet Neurol 2009
222
12

Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.
Marios Politis, Nicola Pavese, Yen F Tai, Lorenzo Kiferle, Sarah L Mason, David J Brooks, Sarah J Tabrizi, Roger A Barker, Paola Piccini. Hum Brain Mapp 2011
129
12

Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease.
Danielle A Simmons, Malcolm Casale, Betzi Alcon, Nha Pham, Natasha Narayan, Gary Lynch. Glia 2007
172
12

Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease.
Han-Yun Hsiao, Feng-Lan Chiu, Chiung-Mei Chen, Yih-Ru Wu, Hui-Mei Chen, Yu-Chen Chen, Hung-Chih Kuo, Yijuang Chern. Hum Mol Genet 2014
68
16

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
11


Plasma inflammatory biomarkers for Huntington's disease patients and mouse model.
Kuo-Hsuan Chang, Yih-Ru Wu, Yi-Chun Chen, Chiung-Mei Chen. Brain Behav Immun 2015
77
12

WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
David A Price, Alex A Martinez, Alexandre Seillier, Wouter Koek, Yolanda Acosta, Elizabeth Fernandez, Randy Strong, Beat Lutz, Giovanni Marsicano, James L Roberts,[...]. Eur J Neurosci 2009
164
11

Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease.
C García, C Palomo-Garo, M García-Arencibia, Ja Ramos, Rg Pertwee, J Fernández-Ruiz. Br J Pharmacol 2011
116
11

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease.
Alicia López, Noelia Aparicio, M Ruth Pazos, M Teresa Grande, M Asunción Barreda-Manso, Irene Benito-Cuesta, Carmen Vázquez, Mario Amores, Gonzalo Ruiz-Pérez, Elena García-García,[...]. J Neuroinflammation 2018
62
16

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
S Galiègue, S Mary, J Marchand, D Dussossoy, D Carrière, P Carayon, M Bouaboula, D Shire, G Le Fur, P Casellas. Eur J Biochem 1995
10

Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington's disease brain.
Megan J Dowie, Natasha L Grimsey, Therri Hoffman, Richard L M Faull, Michelle Glass. J Chem Neuroanat 2014
21
42

Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.
Hai-Ying Zhang, Ming Gao, Qing-Rong Liu, Guo-Hua Bi, Xia Li, Hong-Ju Yang, Eliot L Gardner, Jie Wu, Zheng-Xiong Xi. Proc Natl Acad Sci U S A 2014
218
10

Identification and functional characterization of brainstem cannabinoid CB2 receptors.
Marja D Van Sickle, Marnie Duncan, Philip J Kingsley, Abdeslam Mouihate, Paolo Urbani, Ken Mackie, Nephi Stella, Alexandros Makriyannis, Daniele Piomelli, Joseph S Davison,[...]. Science 2005
10

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation.
Jared Ehrhart, Demian Obregon, Takashi Mori, Huayan Hou, Nan Sun, Yun Bai, Thomas Klein, Francisco Fernandez, Jun Tan, R Douglas Shytle. J Neuroinflammation 2005
265
9

Imaging microglial activation in Huntington's disease.
Yen F Tai, Nicola Pavese, Alexander Gerhard, Sarah J Tabrizi, Roger A Barker, David J Brooks, Paola Piccini. Brain Res Bull 2007
102
9

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.
Katarzyna Maresz, Erica J Carrier, Eugene D Ponomarev, Cecilia J Hillard, Bonnie N Dittel. J Neurochem 2005
337
9

Nonpsychotropic cannabinoid receptors regulate microglial cell migration.
Lisa Walter, Allyn Franklin, Anke Witting, Christian Wade, Yiheng Xie, George Kunos, Ken Mackie, Nephi Stella. J Neurosci 2003
458
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.